CytomX Therapeutics Inc. (CTMX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
2.28
0.18 (8.57%)
At close: Sep 05, 2025, 3:59 PM
2.29
0.44%
After-hours: Sep 05, 2025, 06:36 PM EDT

CytomX Therapeutics Revenue

CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending June 30, 2025, CytomX Therapeutics generated $18.66M in revenue.
Revenue (ttm)
138.1M
Revenue Growth
36.45%
Price / Sales Ratio
0.63
Revenue / Employee
1.16M
Employees
119
Market Cap
376M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 138.1M +36.45%
Dec 31, 2023 101.21M +90.38%
Dec 31, 2022 53.16M -23.59%
Dec 31, 2021 69.57M -30.68%
Dec 31, 2020 100.36M +74.58%
Dec 31, 2019 57.49M -3.38%
Dec 31, 2018 59.5M -16.92%
Dec 31, 2017 71.62M +376.12%
Dec 31, 2016 15.04M +95.06%
Dec 31, 2015 7.71M +51.90%
Dec 31, 2014 5.08M +471.73%
Dec 31, 2013 888K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.